Drug Maker Mylan Agrees to Settle Medicaid Case for $65 Million

more+
less-

The drug maker Mylan Inc. has agreed to settle a lawsuit brought against it by both the U.S. government and the State of Texas. The suit alleges that Mylan artificially inflated prescription drug prices, causing Medicaid to pay the company far more money than should have been reasonable. Mylan will pay $65 million under the terms of the settlement, while admitting no wrongdoing. Mylan is a generic-drug manufacturer located in Pittsburgh.

Please see full article below for more information.

LOADING PDF: If there are any problems, click here to download the file.


DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Robert Kraft, Kraft & Associates | Attorney Advertising

Written by:

more+
less-

Kraft & Associates on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.
×
Loading...
×
×